Search

Your search keyword '"Anjum, Muhammed"' showing total 3 results
Start Over Author "Anjum, Muhammed"
3 results on '"Anjum, Muhammed"'

1. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial

Author

Li, Xiaobo, Ge, Zhen, Kan, Jing, Anjum, Muhammed, Ye, Fei, Gao, Xiaofei, Jalal, Anjum, Xie, Ping, Tao, Ling, Chen, Xiang, Khan, Hamid S, Javed, Asim, Shao, Yibin, Guo, Xiaomei, Li, Feng, Saghir, Tahir, Mengal, Naeem, Nie, Shaoping, Qu, Hong, Qian, Xuesong, Yang, Song, Chen, Jing, Gao, Dasheng, Liu, Lijun, Wang, Mingliang, Chen, Lianglong, Liu, Fan, Xu, Tan, Liu, Yinwu, Gill, Badar Ul Ahad, Yang, Qing, Guo, Nin, Wen, Shangyu, Cong, Hongliang, Hong, Lang, Sheiban, Imad, Raza, Afsar, Wei, Yongyue, Chen, Feng, Mintz, Gary S, Zhang, Jun-Jie, Stone, Gregg W, Chen, Shao-Liang, Khan, Hamid Sharif, and Guo, Ning

Published
2024
Full Text
View/download PDF

2. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

Author

Li, Xiaobo, Ge, Zhen, Kan, Jing, Anjum, Muhammed, Ye, Fei, Gao, Xiaofei, Jalal, Anjum, Xie, Ping, Tao, Ling, Chen, Xiang, Khan, Hamid S, Javed, Asim, Shao, Yibin, Guo, Xiaomei, Li, Feng, Saghir, Tahir, Mengal, Naeem, Nie, Shaoping, Qu, Hong, Qian, Xuesong, Yang, Song, Chen, Jing, Gao, Dasheng, Liu, Lijun, Wang, Mingliang, Chen, Lianglong, Liu, Fan, Xu, Tan, Liu, Yinwu, Gill, Badar Ul Ahad, Yang, Qing, Guo, Nin, Wen, Shangyu, Cong, Hongliang, Hong, Lang, Sheiban, Imad, Raza, Afsar, Wei, Yongyue, Chen, Feng, Mintz, Gary S, Zhang, Jun-Jie, Stone, Gregg W, Chen, Shao-Liang, Mohydin, Bilal S, Gao, Fentang, Shao, Yibing, Wang, Yan, Zeng, Hesong, and Khan, Hamid Sharif

Published
2024
Full Text
View/download PDF

3. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

Author

Ge, Zhen, Kan, Jing, Gao, Xiaofei, Raza, Afsar, Zhang, Jun-Jie, Mohydin, Bilal S, Gao, Fentang, Shao, Yibing, Wang, Yan, Zeng, Hesong, Li, Feng, Khan, Hamid Sharif, Mengal, Naeem, Cong, Hongliang, Wang, Mingliang, Chen, Lianglong, Wei, Yongyue, Chen, Feng, Stone, Gregg W, Chen, Shao-Liang, Li, Xiaobo, Ge, Zhen, Kan, Jing, Anjum, Muhammed, Ye, Fei, Gao, Xiaofei, Jalal, Anjum, Xie, Ping, Tao, Ling, Chen, Xiang, Khan, Hamid S, Javed, Asim, Shao, Yibin, Guo, Xiaomei, Li, Feng, Saghir, Tahir, Mengal, Naeem, Nie, Shaoping, Qu, Hong, Qian, Xuesong, Yang, Song, Chen, Jing, Gao, Dasheng, Liu, Lijun, Wang, Mingliang, Chen, Lianglong, Liu, Fan, Xu, Tan, Liu, Yinwu, Gill, Badar Ul Ahad, Yang, Qing, Guo, Nin, Wen, Shangyu, Cong, Hongliang, Hong, Lang, Sheiban, Imad, Raza, Afsar, Wei, Yongyue, Chen, Feng, Mintz, Gary S, Zhang, Jun-Jie, Stone, Gregg W, and Chen, Shao-Liang

Abstract

Following percutaneous coronary intervention with stent placement to treat acute coronary syndromes, international clinical guidelines generally recommend dual antiplatelet therapy with aspirin plus a P2Y12receptor inhibitor for 12 months to prevent myocardial infarction and stent thrombosis. However, data on single antiplatelet therapy with a potent P2Y12inhibitor earlier than 12 months after percutaneous coronary intervention for patients with an acute coronary syndrome are scarce. The aim of this trial was to assess whether the use of ticagrelor alone, compared with ticagrelor plus aspirin, could reduce the incidence of clinically relevant bleeding events without an accompanying increase in major adverse cardiovascular or cerebrovascular events (MACCE).

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results